These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 300842

  • 1. Relation of protease inhibitor phenotypes to obstructive lung diseases in a community.
    Morse JO, Lebowitz MD, Knudson RJ, Burrows B.
    N Engl J Med; 1977 May 26; 296(21):1190-4. PubMed ID: 300842
    [Abstract] [Full Text] [Related]

  • 2. Alpha 1-antitrypsin phenotypes and obstructive lung disease in the city of Oslo.
    Gulsvik A, Fagerhol MK.
    Scand J Respir Dis; 1979 Oct 26; 60(5):267-74. PubMed ID: 316573
    [Abstract] [Full Text] [Related]

  • 3. A community study of the relation of alpha1-antitrypsin levels to obstructive lung diseases.
    Morse JO, Lebowitz MD, Knudson RJ, Burrows B.
    N Engl J Med; 1975 Feb 06; 292(6):278-81. PubMed ID: 1078596
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population.
    McDonagh DJ, Nathan SP, Knudson RJ, Lebowitz MD.
    J Clin Invest; 1979 Feb 06; 63(2):299-309. PubMed ID: 311786
    [Abstract] [Full Text] [Related]

  • 7. [Typologic analysis of comparative effects of tobacco and Pi phenotype on the respiratory function].
    Doré MF, Orvoen-Frija E, Labrousse F, Barrault N, Lebeau B, Jacquemin C.
    Bull Eur Physiopathol Respir; 1982 Feb 06; 18(5):717-24. PubMed ID: 6985439
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alpha1-antitrypsin phenotypes and lung function in a moderately polluted northern Ontario community.
    Ostrow DN, Manfreda J, Dorman T, Cherniack RM.
    Can Med Assoc J; 1978 Mar 18; 118(6):669-72. PubMed ID: 306869
    [Abstract] [Full Text] [Related]

  • 10. Interrelationships between serum chemotactic factor inactivator, alpha 1-antitrypsin deficiency, and chronic obstructive lung disease.
    Lam S, Chan-Yeung M, Abboud R, Kreutzer D.
    Am Rev Respir Dis; 1980 Mar 18; 121(3):507-12. PubMed ID: 6968167
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chronic obstructive pulmonary disease and alpha-1-antitrypsin (Pi) variation: a family study.
    Benjamin JJ, Cohen BH, Ball WC, Levy DA, Menkes HA, Kreiss P.
    Birth Defects Orig Artic Ser; 1974 Mar 18; 10(4):212-6. PubMed ID: 4549777
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Is the PiF allele of alpha 1-antitrypsin associated with pulmonary disease?
    Beckman G, Stjernberg NL, Eklund A.
    Clin Genet; 1984 Jun 18; 25(6):491-5. PubMed ID: 6610506
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Phenotypes Pi MS, MZ alpha, antitrypsin and lung disease].
    Patterson CD, Mackenthun A, Anderson PS, Hammarsten JF.
    Bull Int Union Tuberc; 1976 Jun 18; 51(1 Pt 2):675-9. PubMed ID: 1088747
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.